Phenotypic switching in Cryptococcus neoformans

被引:28
作者
Guerrero, A
Jain, N
Goldman, DL
Fries, BC [1 ]
机构
[1] All India Inst Med Sci, Dept Microbiol & Immunol, New Delhi, India
[2] All India Inst Med Sci, Dept Microbiol, New Delhi, India
[3] Albert Einstein Coll Med, Dept Pediat, Bronx, NY 10461 USA
[4] Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA
来源
MICROBIOLOGY-SGM | 2006年 / 152卷
关键词
D O I
10.1099/mic.0.28451-0
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Phenotypic switching has been described in serotype A and D strains of Cryptococcus neoformans. It occurs in vivo during chronic infection and is associated with differential gene expression and changes in virulence. The switch involves changes in the polysaccharide capsule and cell wall that affect the yeast's ability to resist phagocytosis. In addition, the phenotypic switch variants elicit qualitatively different inflammatory responses in the host. In animal models of chronic cryptococosis, the immune response of the host ultimately determines which of the switch variants are selected and maintained. The importance of phenotypic switching is further underscored by several findings that are relevant in the setting of human disease. These include the ability of the mucoid colony variant of RC-2 (RC-2 MC) but not the smooth variant (RC-2 SM) to promote increased intracerebral pressure in a rat model of cryptococcal meningitis. Furthermore, chemotherapeutic and immunological antifungal interventions can promote the selection of the RC-2 MC variant during chronic murine infection.
引用
收藏
页码:3 / 9
页数:7
相关论文
共 58 条
[1]   Molecular subtypes and antifungal susceptibilities of serial Cryptococcus neoformans isolates in human immunodeficiency virus - Associated cryptococcosis [J].
Brandt, ME ;
Pfaller, MA ;
Hajjeh, RA ;
Graviss, EA ;
Rees, J ;
Spitzer, ED ;
Pinner, RW ;
Mayer, LW ;
Stephens, D ;
Farley, M ;
Rimland, D ;
Baughman, W ;
Lao, C ;
Otte, J ;
Harvey, C ;
Hamill, R ;
Reingold, AL ;
Rothrock, G ;
Pattni, B ;
Daily, P .
JOURNAL OF INFECTIOUS DISEASES, 1996, 174 (04) :812-820
[2]   Trends in antifungal drug susceptibility of Cryptococcus neoformans isolates in the United States:: 1992 to 1994 and 1996 to 1998 [J].
Brandt, ME ;
Pfaller, MA ;
Hajjeh, RA ;
Hamill, RJ ;
Pappas, PG ;
Reingold, AL ;
Rimland, D ;
Warnock, DW .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (11) :3065-3069
[3]   CRYPTOCOCCUS NEOFORMANS .3. INHIBITION OF PHAGOCYTOSIS [J].
BULMER, GS ;
SANS, MD .
JOURNAL OF BACTERIOLOGY, 1968, 95 (01) :5-&
[4]   Host-pathogen interactions: Redefining the basic concepts of virulence and pathogenicity [J].
Casadevall, A ;
Pirofski, LA .
INFECTION AND IMMUNITY, 1999, 67 (08) :3703-3713
[5]   Host-pathogen interactions: The attributes of virulence [J].
Casadevall, A ;
Pirofski, LA .
JOURNAL OF INFECTIOUS DISEASES, 2001, 184 (03) :337-344
[6]   TRANSPOSABLE ELEMENTS AS MUTATOR GENES IN EVOLUTION [J].
CHAO, L ;
VARGAS, C ;
SPEAR, BB ;
COX, EC .
NATURE, 1983, 303 (5918) :633-635
[7]   Variants of a Cryptococcus neoformans strain elicit different inflammatory responses in mice [J].
Chen, LC ;
Casadevall, A .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1999, 6 (02) :266-268
[8]  
Cherniak R, 1998, CLIN DIAGN LAB IMMUN, V5, P146
[9]   VARIATION IN THE STRUCTURE OF GLUCURONOXYLOMANNAN IN ISOLATES FROM PATIENTS WITH RECURRENT CRYPTOCOCCAL MENINGITIS [J].
CHERNIAK, R ;
MORRIS, LC ;
BELAY, T ;
SPITZER, ED ;
CASADEVALL, A .
INFECTION AND IMMUNITY, 1995, 63 (05) :1899-1905
[10]   STEROL COMPOSITIONS AND SUSCEPTIBILITIES TO AMPHOTERICIN-B OF ENVIRONMENTAL CRYTOCOCCUS NEOFORMANS ISOLATES ARE CHANGED BY MURINE PASSAGE [J].
CURRIE, B ;
SANATI, H ;
IBRAHIM, AS ;
EDWARDS, JE ;
CASADEVALL, A ;
GHANNOUM, MA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (09) :1934-1937